This compound is primarily utilized in the pharmaceutical industry for its potential therapeutic properties. It is often investigated for its role as an intermediate in the synthesis of more complex drug molecules, particularly those targeting neurological and psychiatric conditions. The structure suggests it may interact with neurotransmitter systems, making it a candidate for research in treating disorders such as depression, anxiety, or chronic pain. Additionally, its chiral nature allows for selective binding to biological targets, enhancing its efficacy and reducing side effects in drug development. Researchers also explore its application in asymmetric synthesis, leveraging its stereochemistry to produce enantiomerically pure compounds.